|1.||Sinha, Uma: 1 article (11/2003)|
|2.||André, Patrick: 1 article (11/2003)|
|3.||Vincent, Diana: 1 article (11/2003)|
|4.||Conley, Pamela B: 1 article (11/2003)|
|5.||Phillips, David R: 1 article (11/2003)|
|6.||Lin, Pei Hua: 1 article (11/2003)|
|7.||LaRocca, Thomas: 1 article (11/2003)|
|8.||Delaney, Suzanne M: 1 article (11/2003)|
11/25/2003 - "In contrast, CT50547 inhibited thrombosis in aspirin-treated individuals independently of the anticoagulant. "
11/25/2003 - "CT50547, a direct-acting P2Y12 antagonist, inhibited thrombosis in PPACK- but not heparin-anticoagulated human blood. "
11/25/2003 - "Thrombin and TXA2 also synergized with P2Y12 in the absence of anticoagulation, because combined treatment of aspirin or C921-78 (a factor Xa inhibitor) with CT50547 or 2-MeSAMP (a P2Y12 antagonist) inhibited the thrombotic process, whereas all treatments failed to inhibit thrombosis when used individually. "
|3.||Aspirin (Acetylsalicylic Acid)
|5.||phenylalanyl- prolyl- arginine- chloromethyl ketone (PPACK)